AU Patent

AU2005210151B2 — Inhibitors of TGF-R signaling for treatment of CNS disorders

Assigned to Aigner Ludwig Dr · Expires 2010-07-01 · 16y expired

What this patent protects

Patent listed against nusinersen-sodium.

Drugs covered by this patent

nusinersen-sodium (NUSINERSEN SODIUM)

Patent Metadata

Patent number: AU2005210151B2
Jurisdiction: AU
Classification: —
Expires: 2010-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Aigner Ludwig Dr
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.